瘤透性淋巴细胞疗法用于晚期黑色素瘤患者
Sebastian Klobuch1, Tom T P Seijkens1,2, Ton N Schumacher3,4
1Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
Nature reviews. Clinical oncology
|January 9, 2024
概括
使用瘤透淋巴细胞 (TILs) 的采用细胞疗法为晚期黑色素瘤患者提供长期益处,即使这些患者对其他治疗方法有抗性. 本综述涵盖了TIL疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 先进的黑色素瘤治疗已经被免疫检查点抑制剂 (ICI) 和BRAF/MEK抑制剂彻底改变.
- 尽管取得了进展,但晚期黑色素瘤的5年生存率仍然不够理想,需要新的治疗方法.
- 瘤透淋巴细胞 (TILs) 疗法已成为一种有前途的细胞免疫疗法,用于晚期黑色素瘤.
研究的目的:
- 审查目前TIL治疗晚期黑色素瘤的现状.
- 讨论TIL治疗产品的特性及其临床益处.
- 探索未来的策略,以提高基于TIL的免疫疗法的疗效.
主要方法:
- 对现有的II/III期临床试验和关于TIL治疗晚期黑色素瘤的文献进行审查.
- 对TIL治疗产品特性和制造工艺的分析.
- 检查临床结果,包括其他疗法进展的患者的反应.
主要成果:
- 在晚期黑色素瘤的II/III期试验中,TIL治疗已经证明了长期的临床益处.
- 在ICI和/或BRAF/MEK抑制剂下疾病进展的患者中,TIL疗法显示出有效性.
- 预计TIL疗法即将获得营销许可,这意味着它们的临床验证.
结论:
- TIL疗法在治疗晚期黑色素瘤方面取得了重大进展,提供了持久的反应.
- 这种细胞免疫疗法即使在耐标准治疗的患者中也是有效的.
- 未来专注于优化TIL治疗的研究预计将进一步改善患者的治疗结果.
更多相关视频
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
9.9K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
768
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
